Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH

Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH